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ABSTRACT
INTRODUCTION Surgical site infection is associated with significant morbidity and mortality. Effective preoperative skin decolo-
nisation is an important preventative strategy. The National Institute for Health and Care Excellence clinical guidelines recom-
mend decolonisation using chlorhexidine gluconate (CHG) or povidone iodine (PVI). Current evidence indicates that CHG is
more effective, while the combination of CHG and PVI is greater still. This study describes current practice among neurosur-
geons in the UK, including differences between trainees and consultants, to review compliance with the latest evidence.
MATERIALS AND METHODS A Society of British Neurosurgical Surgeons approved national, multicentre questionnaire was circu-
lated online. A total of 74 complete responses were obtained from 27 trainees and 47 consultants, representing 28 of 37 neu-
rosurgical centres.
RESULTS Of the total responding centres, 36 (49%) used a single agent and 38 (51%) used a dual-agent preparation. One
respondent used Tisept®. Seventy (95%) used alcohol in some form and none used aqueous CHG. Trainees were more likely to
use a dual-agent preparation (P = 0.025). Forty-seven (63%) prepared the skin three or more times, with trainees preparing the
skin more times than consultants (P = 0.002).
CONCLUSION Neurosurgical practice adheres to national clinical guidelines but not the latest evidence from the literature.
Given the weighting placed on randomised controlled trials, such a trial may be required to standardise practice that is likely to
reduce surgical site infection.
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Introduction
Surgical site infection is associated with significant morbid-
ity and mortality. In neurosurgery, although relatively
infrequent, its occurrence has major clinical consequences
on patient care, with most patients requiring further sur-
gery, intravenous and/or intrathecal antibiotics and pro-
longed hospital admission.1,2 Surgical site infections
require greater resources and increase the cost of care
delivery, with one study reporting a cost of £9,283 per cra-
niotomy infection.3 Its occurrence has implications for sub-
sequent treatment, for example delaying and perhaps
preventing adjuvant therapy in neuro-oncology.4 Conse-
quently, neurosurgical patients with surgical site infection
are more likely to experience poorer outcomes, be disabled
or die.1,4 Qualitative studies have reported the adverse psy-
chological impact of surgical site infection among patients,
such as feelings of depression and despair.5
Surgical site infection causation and prevention
challenges
The development of surgical site infection is thought to
occur when bacterial contamination of the surgical site
overwhelms the host’s innate immune system. Skin com-
mensals, such as Staphylococcus aureus and coagulase-
negative staphylococci and, to a lesser extent, Enterococcus
spp., Escherichia coli, Pseudomonas aeruginosa and
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Enterobacter spp.6 are the most common pathogenic organ-
isms. The patient’s skin is thought to be the primary source
of bacterial infection, making preoperative decolonisation
and intraprocedural asepsis a primary focus for preventa-
tive strategies.
Research into preventative strategies for surgical site
infection is challenged by a low event rate across surgical
specialties, including neurosurgery. This low event rate,
combined with research using small sample sizes, hetero-
geneous case mixes and the multifaceted approach to pre-
vent it, for example with the use of care bundles,7 means
that individual strategies to combat surgical site infection
are difficult to identify.8 Many strategies are thus intro-
duced based on logical rationale rather than high-level evi-
dence. This is likely to influence their uptake, as adopted
strategies vary amongst surgeons, with practice informed
by training, experience and personal preference.
An exception is preoperative skin antisepsis, which
through randomised clinical trials (RCTs) has shown an
impact on the occurrence of surgical site infection.9 This
probably underpins the growing use of skin swabs and bac-
terial counts as surrogate markers for surgical site infec-
tion interventions, given the low event rates of such
infections.
Preoperative decolonisation
The objective of preoperative decolonisation is to reduce
the number of bacteria available to colonise and infect a
wound.9 As a process, it is logical to consider the choice of
agent, number of applications and duration of cleaning to
be key factors. In preclinical experiments, only the agent
and number of applications have been shown to make a
difference, with no additional benefit from more than three
applications.10 In clinical practice, the method of cleaning
has not been found to influence surgical site infection.11
There are limited data regarding the duration of antiseptic
cleaning in achieving adequate preoperative decolonisation
and this is a noted limitation.12,13 Only the choice of agent
has been shown to make a difference.12–16
Popular agents include chlorhexidine gluconate (CHG)
and/or povidone iodine (PVI), with or without alcohol. Sev-
eral published meta-analyses comparing the efficacy of
CHG and PVI have found greater efficacy with CHG over
PVI, although this is largely informed by a single RCT in
patients undergoing caesarean section.9,12–17 In addition,
their application in an alcohol solution as compared with
an aqueous solution is probably more effective. This is
more clearly the case for CHG.17 However, we have
recently demonstrated through meta-analysis18 and a large
prospective series19 that CHG in combination with PVI is
more effective at reducing surgical site infection than a
single agent alone. This is reinforced with precedent that
CHG and PVI have different mechanisms of action and effi-
cacy against bacterial and fungal pathogens and ultimately
have a theoretical synergistic effect.20 Therefore, while the
2017 National Institute for Health and Care Excellence
(NICE) clinical guidelines recommend CHG or PVI in isola-
tion, in either alcoholic or aqueous preparations,21 the lit-
erature suggests a step-wise benefit towards CHG-alcohol
and more recently, further benefit of CHG-alcohol in com-
bination with PVI.
Current practice and scope for survey
There are no descriptions of current preoperative practice
in UK neurosurgery. It is likely informed by NICE clinical
guidelines, but exact preferences are unknown. The only
prior example of surveying antiseptic practice comes from
the United States, although hospital representatives were
surveyed and not individual surgeons.22 The aim of this
survey was to explore contemporary neurosurgical practice
across UK centres and to compare practice between train-
ees and consultants.
Materials and methods
A Society of British Neurosurgical Surgeons approved
online, national, multiple-choice questionnaire was circu-
lated via email to its associate (trainees) and full (consul-
tant) members. The survey was designed using
SurveyMonkey. Different weblinks (known as collectors)
were used to gather data from trainee and consultant neu-
rosurgeons. As per guidance from the academic committee
of the Society, only two emails were sent (a month apart)
for this survey. In addition to questions regarding preoper-
ative practice, questions were included to assess the appe-
tite for and potential practicalities of a prospective study.
Figure 1 shows the questions that were used online.
Statistical analysis
Collected data were categorical and are presented using
summary statistics. For comparison between trainees and
consultants, a Chi-square test was performed using
SPSS® Statistics version 22.0 (IBM). Graphs were pro-
duced using GraphPad PRISM® 7. The level of signifi-
cance for all statistical analyses was defined as P < 0.05.
Results
The survey had 74 respondents (27 trainees, 47 consul-
tants) from 28 of 37 (76%) neurosurgical centres across
the UK. Nineteen centres (51%) had more than one
respondent. All surveys were fully completed.
There was clinical equipoise between the use of single
(n = 36; 49%) and dual (n = 38; 51%) agent preoperative
antisepsis (Fig 2). Trainees were more likely to use a dual-
agent preparation (P = 0.025). Of the single-agent prepara-
tions, PVI alcohol was most popular (n = 20; 56%), followed
by CHG-alcohol (n = 13; 36%) then aqueous PVI (n = 3;
8%). No surgeons reported using aqueous CHG. Within
this subgroup, no trainee used only CHG-alcohol, instead
showing a preference for aqueous PVI.
Of the dual-agent preparations, the combination of CHG-
alcohol and PVI-alcohol was most popular (n = 26; 68%),
followed by aqueous PVI and alcohol-CHG (n = 11; 29%)
and aqueous PVI and Tisept® (MoInlycke Health Care;
n = 1; 3%). Tisept is a combination of chlorhexidine and
cetrimide, a broad-spectrum antiseptic. It comes as an
aqueous preparation. For the remainder, alcohol in some
form was used by 70 (95%) of respondents.
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There was variation in the number of applications of
skin preparations (Fig 3). Three or more applications was
the most popular option (64%). Consultants were evenly
distributed between categories. Trainees were more likely
to clean the skin more times than consultants (P = 0.002).
There was no significant difference between the use of sin-
gle and dual agents influencing the number of prepara-
tions, (P = 0.423).
Internet connectivity in theatre to access a randomisa-
tion-based platform for any future clinical trial was also
surveyed, with 73 (99%) of respondents stating that their
centre had access. Sixty respondents (81% – 78% of
trainees and 83% of consultants) stated that they would
be interested in participating in a prospective skin prepa-
ration study. For ease of auditing, electronic patient
records were surveyed, as they were present in three
centres surveyed: Addenbrooke’s Hospital, Cambridge;
St. George’s Hospital, London and Salford Royal Hospital,
Salford.
Discussion
All neurosurgeons used CHG or PVI preparations, in
accordance with NICE clinical guidelines.21 Alcohol was
used in almost all cases (95%), in combination with either
CHG or PVI, but CHG was never used as an aqueous prep-
aration. Half of neurosurgeons used both CHG and PVI in
combination and this was more common amongst trainees
than consultants. Trainees applied agents more often than
consultants.
Questionnaire
1 Unit name
2 How many clean cranial cases (excluding implant cases such as ventriculoperitoneal 
shunt, deep bran stimulation, etc) are performed at your unit? Please specify this if 
this is from departmental audit data, or an estimate.
3 Do you routinely collect SSI data?
Yes / No
4 If yes, what is your overall cranial neurosurgery infection rate?
5 What skin preparation do you use?
Skin Preparation As single As combination (specify name(s))
Alcoholic Chlorhexidine (AL-CHG)
Alcoholic Betadine (AL-PVI)
Chlora-prep (AQ-CHG)
Aqueous Betadine (AQ-PVI)
Other (specify)
6 How many times do you prepare the skin?
Once Twice Three times More than three times
7 Would you consider taking part in a randomised trial to test the efficacy of double skin 
preparation versus single skin preparation in clean cranial surgery?
Yes / No
8 Does your hospital have electronic patient records (for outpatients, inpatient records, 
operation details and readmissions) ?
Yes – completely paperless Yes – almost paperless
Yes – only 50% of records Not really
9 Do you have internet access in theatre to access a web based randomisation 
platform?
Yes / No
Figure 1 Survey design.
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While there are weaknesses in the evidence underpin-
ning these meta-analyses, the present literature points to
stepwise benefits for CHG over PVI and alcohol over aque-
ous preparations. More recently, we have shown potential
benefit for the use of CHG in combination with PVI;18 in a
case series of 2603 cranial cases, the combination of CHG
and PVI was shown to reduce the risk of surgical site infec-
tion.19 This is supported by a series of 407 patients under-
going elective spinal surgery23 and in high-risk patients in
an RCT of patients undergoing caesarean section.24 The
impact of the number of applications of antiseptic on surgi-
cal site infection is not well known but an in vivo experi-
ment demonstrated that maximal effect on decolonisation
is seen after three applications.10
In this survey, we have shown that neurosurgical prac-
tice adheres to NICE guidelines, but practice does not
reflect contemporary evidence regarding the choice of
antiseptic agent. This is also reflected in a similar survey
of neurosurgical centres in the United States.22 Kalb et al22
found that no one used a dual combination of PVI and CHG
and concluded that departments continued to use iodine-
based solutions in preference to CHG despite trends in the
literature that CHG was probably superior to PVI.9,12,13,15,16
There are many barriers to changing surgical practice.
Surgical practice is influenced by longstanding routine,
once informed by training and personal preference, sub-
sequently reinforced with clinical experience. This may
reflect the finding in this survey that practice differed
between consultants and trainees, with trainees more
likely to use a combination of CHG and PVI, the poten-
tially most effective protocol. It is noteworthy that train-
ees were also more likely to clean the skin more than
three times. This may also be a more effective method.
This suggests that trainees, in still developing their prac-
tice, may be more receptive and less resistant to change,
albeit among the single-agent group, trainees did not use
CHG-alcohol.
The far-reaching implications of surgical site infection
mandate research and evidence-based practice. The cost of
a surgical site infection is not just devastating in neurosur-
gery,3 but also across all surgical specialties. A Cochrane
review extrapolated the cost of surgical site infection in an
acute hospital setting and approximated it at £1 billion.9
There are clear clinical, financial3,9 and patient-centred
incentives5 for reducing the incidence of surgical site
infection. While many interventions have been explored,
including combination techniques such as ‘bundles’, the
results have been mixed. The evidence behind types of
skin preparation is more consistent and represents a sim-
ple intervention with evidenced impact.
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Figure 2 Choice of skin preparation; 36 (49%) and 38 (51%) of respondents used single or double antisepsis preparations, respectively.
Trainees were more likely to use a dual-agent preparation (P = 0.025).
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The finding in this survey of overwhelming support for
participation, across trainees and consultants, in a prospec-
tive skin preparation study is therefore welcome. It would
also suggest there is appetite for change to surgeons’ pre-
operative practice. The question therefore arises, given the
significance of surgical site infection and the evidence
already in existence: what additional information is
required to drive change; what changes surgical practice?
This is an important question and one that has not been
clearly addressed within any surgical field. We assume that
it is informed by ‘evidence’, but if there is evidence, per-
haps it is the type of evidence that matters.
It is recognised that the quality of evidence, in particular
the influence of bias, has to be considered when interpret-
ing a study’s findings; evidence-based medicine has cre-
ated ‘levels of evidence’ to help reference the strength of
any recommendations.25 These categorical systems place
well-designed RCTs at the top level. Thus, although such
trials come with their own limitations,26 and other study
designs may better inform clinical practice in certain sce-
narios, the RCT has become synonymous with ‘gold stand-
ard’ assessment and entrenched in the clinical psyche;27
they form the basis for most guideline recommendations
and incidentally are suggested in the conclusions of the
aforementioned skin preparation meta-analyses, including
the Cochrane reviews.9,13 By extension, we speculate that
this is required to change surgical practice.
Limitations
The sample size of this survey was small, but it covers
most UK neurosurgical units.
Conclusions
Neurosurgical practice adheres to NICE clinical guidance
on preoperative antisepsis, but it does not accord with the
latest evidence in the literature. Guidelines are typically
informed by RCTs and the burden and impact of surgical
site infection mandates further action. There is potential
for a simple change in preoperative antisepsis to make a
clinical difference that is not the current standard of care.
It is therefore probable that a well-designed RCT is
required. While a comparison between CHG-alcohol and
CHG/PVI-alcohol would be most straightforward, additional
comparison against PVI-alcohol alone would allow this
chapter of research to be concluded.
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Figure 3 Number of preparation applications. Trainees were more likely to clean the skin more times than a consultant (P = 0.002).
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